GENOCEA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | 0.00% |
| 2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
| 2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
Chart calendar Genocea Biosciences, Inc.
f457ee8fbe965741260bf.tOKkwUK5EHYoH_tFxdFcLay7-S5Nf1pn-RFEG0tlFQM.99PJmyPXQjR7esh1jJU9YMXcpkojOTsrjCIBax5VT0TxlJ2uFNJfRW5eug~f2d7a038b50a36230391c68db9c01e05
Upcoming events on Genocea Biosciences, Inc.
No events available
Past events on Genocea Biosciences, Inc.
| 12/04/2022 11:45 pm | Needham Virtual Healthcare Conference |
| 12/04/2022 07:30 pm | American Association of Cancer Research Meeting - Poster #2745 |
| 12/04/2022 12:00 am | American Association of Cancer Research Meeting - Poster #CT153 |
| 12/04/2022 12:00 am | American Association of Cancer Research Meeting - Poster #2088 |
| 09/04/2022 02:00 am | American Association of Cancer Research Meeting |
| 17/03/2022 06:10 pm | Oppenheimer Healthcare Conference |
| 10/03/2022 07:00 pm | FY 2021 Earnings Call |
| 10/03/2022 05:30 pm | FY 2021 Earnings Release |
| 17/02/2022 09:10 pm | SVB Leerink Global Healthcare Conference |
| 27/01/2022 03:30 am | Advanced Therapies Week - Panel |
| 10/01/2022 05:30 pm | H.C. Wainwright BioConnect Conference |
| 08/01/2022 12:30 am | LifeSci Partners Corporate Access Event - Panel |
| 07/01/2022 07:00 pm | LifeSci Partners Corporate Access Event - Panel |
| 07/01/2022 03:40 am | Longwood Healthcare Leaders Winter Webconference |
| 07/01/2022 12:00 am | Longwood Healthcare Leaders Winter Webconference - Panel |
| 05/01/2022 | LifeSci Partners Corporate Access Event |
| 02/12/2021 01:10 am | World Vaccine & Immunotherapy Congress |
| 18/11/2021 03:00 am | Cellular Immunotherapies for Solid Tumors Summit |
| 17/11/2021 11:50 pm | Stifel Healthcare Conference |
| 10/11/2021 | Society for Immunotherapy of Cancer Meeting - Poster No - 753 |
Annual results
| Fiscal Period | December | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,36 1,40 -2.93% | 1,64 1,65 -0.55% |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -38,4 -41,9 8.28% | 0,00 0,00 - | -45,9 -47,5 3.47% | -50,5 -52,6 3.92% |
|
EBIT Million USD | Released Forecast Spread | -55,3 -55,1 -0.28% | -39,5 -41,2 3.97% | -39,0 -39,2 0.49% | -47,0 -47,7 1.43% | -52,1 -51,9 -0.31% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,2 -56,5 0.52% | -27,8 -39,2 28.97% | -39,0 -40,2 2.99% | -43,7 -41,7 -4.83% | -33,2 -31,6 -5.16% |
|
Net income Million USD | Released Forecast Spread | -56,2 -56,5 0.52% | -27,8 -39,2 28.97% | -39,0 -40,0 2.73% | -43,7 -41,5 -5.33% | -33,2 -31,8 -4.26% |
|
EPS USD | Released Forecast Spread | -15,8 -15,8 -0.34% | -2,72 -3,96 31.31% | -1,89 -1,96 3.77% | -0,98 -0,95 -2.94% | -0,48 -0,48 -0.84% |
| Announcement Date | 15/02/18 | 28/02/19 | 13/02/20 | 11/02/21 | 10/03/22 |
Quarterly results
| Fiscal Period | December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,91 0,00 - | 0,45 0,00 - | 0,00 0,10 - | 0,00 0,00 - | 0,00 0,00 - | 1,64 0,00 - | 0,00 0,04 - | 0,27 0,34 -20.59% |
|
EBITDA Million USD | Released Forecast Spread | -13,1 -10,3 -27.17% | -11,4 -12,2 6.2% | -12,0 -11,7 -2.91% | -11,3 -14,7 23% | -13,0 -13,9 6.47% | -15,4 -13,5 -13.87% | |||
|
EBIT Million USD | Released Forecast Spread | -13,4 -10,1 -32.01% | -11,2 -11,5 2.61% | -10,7 -12,2 12.09% | -11,7 -12,5 6.03% | -12,4 -12,1 -2.73% | -14,5 -12,4 -17.72% | -11,7 -13,5 13.3% | -13,4 -13,4 -0.33% | -15,8 -12,7 -24.36% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,9 -9,97 -28.94% | -11,3 -11,5 1.87% | -4,56 -13,7 66.73% | -15,0 -13,0 -15.27% | -12,0 -12,6 4.57% | -4,31 -12,2 64.66% | -3,62 -15,0 75.91% | -13,3 -12,2 -8.95% | -16,0 -12,7 -26.19% |
|
Net income Million USD | Released Forecast Spread | -12,9 -9,99 -28.7% | -11,3 -11,5 1.25% | -4,56 -12,5 63.5% | -15,0 -12,8 -17.13% | -12,0 -12,4 3.29% | -4,31 -12,2 64.79% | -3,62 -14,5 75.08% | -13,3 -12,2 -8.48% | -16,0 -12,8 -25.12% |
|
EPS USD | Released Forecast Spread | -0,46 -0,35 -30.68% | -0,39 -0,40 1.89% | -0,08 -0,26 69.23% | -0,23 -0,21 -10.58% | -0,17 -0,21 17.07% | -0,06 -0,18 67.03% | -0,05 -0,21 76.64% | -0,19 -0,19 -2.15% | -0,22 -0,18 -20.88% |
| Announcement Date | 30/04/20 | 23/07/20 | 29/10/20 | 11/02/21 | 29/04/21 | 29/07/21 | 28/10/21 | 10/03/22 | 05/05/22 |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Genocea Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GNCAQ Stock
- Calendar Genocea Biosciences, Inc.
